Cell lines and commodities: The Hagahai patent case
In March 1995, the United States government issued a patent on a human cell line for an indigenous Hagahai man from the rainforests of Papua New Guinea. The US National Institutes of Health (NIH) were issued patent No. 5,397,696 by the Patent and Trademark Office (PTO), the first time that an indig...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Asia Pacific Network
1997
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/775f578950d74ac98983d44d07020bc7 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | In March 1995, the United States government issued a patent on a human cell line for an indigenous Hagahai man from the rainforests of Papua New Guinea. The US National Institutes of Health (NIH) were issued patent No. 5,397,696 by the Patent and Trademark Office (PTO), the first time that an indigenous person's cells have been patented. Critics saw this is a 'new and dangerous' era in intellectual property rights while even defenders conceded there are serious dilemmas embracing ethics, the law and the media.
|
|---|